Episodios

  • How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System

    How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
    Jul 9 2024
    Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.
    Más Menos
    20 m
  • ASCO 2024 Recap, ADCs, Cell Therapies and RLTs

    ASCO 2024 Recap, ADCs, Cell Therapies and RLTs
    Jun 13 2024
    In this podcast episode, your host, Chris Leidli, MS, MBA, goes beyond the ASCO 2024 headlines and puts a spotlight on the new clinical data for advanced therapies you don't want to miss.
    Más Menos
    19 m
  • ASGCT 2024 Abstracts Preview

    ASGCT 2024 Abstracts Preview
    Apr 23 2024
    In this episode, we preview the top American Society of Gene and Cell Therapy (ASGCT) 2024 annual meeting abstracts with guests Dr. Emily Walsh Martin from Tremont Therapeutics Consulting and Lynnea Olivarez, Incoming Chair of the ASGCT Communications Committee.
    Más Menos
    43 m
  • Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics

    Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics
    Mar 28 2024
    Over the years, electronic health records (EHRs) have revolutionized medical practice, digitizing patient data and streamlining care. But the current systems are not well suited to support collection of real-world data or the tracking of longitudinal outcomes across patient populations. This is particularly true for hematopoietic stem cell transplant and cellular therapies. Our special guest, Dr. Wayne Liang is a leader in the stem cell transplant and cell therapy informatics field. Wayne is Director of Informatics Education and Outreach at Children's Healthcare of Atlanta, he is also a pediatric hematologist/oncologist at Aflac Cancer & Blood Disorders Center, and Assistant Professor of Pediatrics at Emory University.
    Más Menos
    36 m
  • How Ryght is Building a Generative AI Platform for BioPharma

    How Ryght is Building a Generative AI Platform for BioPharma
    Mar 18 2024
    Our guest for this podcast episode is Simon Arkell, CEO of Ryght. Ryght is developing the next generation of safe and secure generative AI to empower Life Science companies to ingest real-time data and make actionable knowledge directly available to discovery, clinical, and commercial teams.
    Más Menos
    27 m
  • Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar

    Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar
    Mar 14 2024
    Our guest for this podcast episode is Doron Behar, MD, PhD, co-founder and CEO of Igentify, a digital health, artificial intelligence and genetic counseling company. In this episode, Dr. Behar shares how his company has developed a medical-grade tech platform that optimizes genomic workflows and produces AI-generated personalized genetic counseling for patients.
    Más Menos
    40 m
  • ASGCT Annual Meeting Preview

    ASGCT Annual Meeting Preview
    Mar 11 2024
    This episode features a preview of the American Society of Gene and Cell Therapy Annual Meeting scientific symposium on the impact of Generative AI on cell and gene therapy (CGT); best practices and real-world applications for communicators. Dr. Rory Bricker-Anthony shares insight into what attendees can expect to learn from the May 2024 session, including current tools and applications for CGT communicators.
    Más Menos
    11 m
  • 2024 Biopharma Investment Outlook with Chris Dokomajilar

    2024 Biopharma Investment Outlook with Chris Dokomajilar
    Feb 12 2024
    Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data. In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and partnership activity in the biopharma space.
    Más Menos
    19 m